ARUP secures CE mark for AAV5 DetectCDx to select patients eligible for BioMarin’s Roctavian
The AAV5 DetectCDx is a companion diagnostic developed in partnership with US-based biotechnology company BioMarin to help identify…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Nov 23
The AAV5 DetectCDx is a companion diagnostic developed in partnership with US-based biotechnology company BioMarin to help identify…
13 Nov 23
The Shield test is designed for the detection of colorectal cancer signals in the bloodstream from DNA that…
13 Nov 23
GC Genome's Genome Health has been developed as a single nucleotide polymorphism (SNP) genotyping service that uses next-generation…
13 Nov 23
Paradise uRDN system is an ultrasound-based renal denervation (RDN) technology, designed to lower blood pressure by denervating overactive…
13 Nov 23
Designed to provide a ready-to-use solution for new inhalation treatments, the PneumoHaler eliminates the need for pharmaceutical companies…
13 Nov 23
NextGen Healthcare shareholders are entitled to receive $23.95 per share in cash. The Company's common stock has ceased…
10 Nov 23
The Flowflex Covid-19 Antigen Home Test is approved for over-the-counter (OTC), at-home use by symptomatic individuals, indicated for…
10 Nov 23
Roche’s Elecsys NfL test offers a minimally invasive testing option that can provide rapid answers to patients and…
10 Nov 23
The EsoGuard Esophageal DNA test is intended to help in preventing cancer and associated death through early detection…
10 Nov 23
The acquisition will greatly enhance and expand technology solutions platform in the minimally invasive and interventional therapies sector